← Back to patent-cliff list
CAS 1707289-90-4
(3S,4S)-N3-(6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)tetrahydro-2H-pyran-3,4-diamine
Codes: Fisogatinib-004
Application context (from source-drug indications)
Hepatocellular carcinomaFisogatinib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Fisogatinib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-chloro-6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazoline→(3S,4S)-4-azidotetrahydro-2H-pyran-3-amine hydrochloride→N-((3S,4S)-4-azidotetrahydro-2H-pyran-3-yl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-amine→(3S,4S)-N3-(6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)tetrahydro-2H-pyran-3,4-diamine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.